Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate)

CHEBI:CHEBI_756383

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

listing_expiration_date
20251231
route
INTRAMUSCULAR
dosage_form
INJECTION, SUSPENSION
product_type
VACCINE
marketing_category
BLA
pharm_class
Inactivated Haemophilus Influenzae B Vaccine [EPC]
labeler_name
Merck Sharp & Dohme LLC
active_ingredient_name
HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN
generic_name
Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate)
brand_name
PedvaxHIB
brand_name_base
PedvaxHIB
product_ndc
0006-4897
application_number
BLA103237
marketing_start_date
19891220
package_marketing_start_date
19891220
spl_id
18aa7f8f-d17c-45da-8b42-97d6e3e8832a
active_ingredient_strength
7.5 ug/.5mL
package_ndc
0006-4897-00
package_description
10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4897-00) / .5 mL in 1 VIAL, SINGLE-DOSE (0006-4897-01)
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class